These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 37792944

  • 1. Simultaneous subset tracing and miRNA profiling of tumor-derived exosomes via dual-surface-protein orthogonal barcoding.
    Lei Y, Fei X, Ding Y, Zhang J, Zhang G, Dong L, Song J, Zhuo Y, Xue W, Zhang P, Yang C.
    Sci Adv; 2023 Oct 06; 9(40):eadi1556. PubMed ID: 37792944
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis.
    Cho S, Yang HC, Rhee WJ.
    Biosens Bioelectron; 2019 Dec 15; 146():111749. PubMed ID: 31600625
    [Abstract] [Full Text] [Related]

  • 3. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH, Ji J, Wang BC, Chen H, Yang ZH, Wang K, Luo CL, Zhang WW, Wang FB, Zhang XL.
    Cell Physiol Biochem; 2018 Dec 15; 46(2):532-545. PubMed ID: 29614511
    [Abstract] [Full Text] [Related]

  • 4. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.
    Clin Transl Oncol; 2017 Jun 15; 19(6):651-657. PubMed ID: 28054319
    [Abstract] [Full Text] [Related]

  • 5. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
    Kim J, Shim JS, Han BH, Kim HJ, Park J, Cho IJ, Kang SG, Kang JY, Bong KW, Choi N.
    Biosens Bioelectron; 2021 Nov 15; 192():113504. PubMed ID: 34298498
    [Abstract] [Full Text] [Related]

  • 6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 15; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 7. Exosomal noncoding RNAs in prostate cancer.
    Movahedpour A, Khatami SH, Karami N, Vakili O, Naeli P, Jamali Z, Shabaninejad Z, Tazik K, Behrouj H, Ghasemi H.
    Clin Chim Acta; 2022 Dec 01; 537():127-132. PubMed ID: 36330945
    [Abstract] [Full Text] [Related]

  • 8. Spatial Confinement-Derived Double-Accelerated DNA Cascade Reaction for Ultrafast and Highly Sensitive In Situ Monitoring of Exosomal miRNA and Exosome Tracing.
    Chen J, Xie M, Shi M, Yuan K, Wu Y, Meng HM, Qu L, Li Z.
    Anal Chem; 2022 Feb 01; 94(4):2227-2235. PubMed ID: 35029990
    [Abstract] [Full Text] [Related]

  • 9. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M, Castells M, Bassas L, Vigués F, Larriba S.
    Sci Rep; 2019 Sep 24; 9(1):13772. PubMed ID: 31551516
    [Abstract] [Full Text] [Related]

  • 10. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
    Lee J, Kwon MH, Kim JA, Rhee WJ.
    Artif Cells Nanomed Biotechnol; 2018 Sep 24; 46(sup3):S52-S63. PubMed ID: 30033809
    [Abstract] [Full Text] [Related]

  • 11. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
    Wang J, Ni J, Beretov J, Thompson J, Graham P, Li Y.
    Crit Rev Oncol Hematol; 2020 Jan 24; 145():102860. PubMed ID: 31874447
    [Abstract] [Full Text] [Related]

  • 12. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J.
    Mol Cancer; 2019 Mar 13; 18(1):40. PubMed ID: 30866952
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ.
    Breast Cancer Res; 2019 Feb 06; 21(1):21. PubMed ID: 30728048
    [Abstract] [Full Text] [Related]

  • 15. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, Mirshahidi S, Mercola D, Lilly MB, Wall NR.
    PLoS One; 2012 Feb 06; 7(10):e46737. PubMed ID: 23091600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring.
    He D, Wang H, Ho SL, Chan HN, Hai L, He X, Wang K, Li HW.
    Theranostics; 2019 Feb 06; 9(15):4494-4507. PubMed ID: 31285775
    [Abstract] [Full Text] [Related]

  • 19. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
    Joković SM, Dobrijević Z, Kotarac N, Filipović L, Popović M, Korać A, Vuković I, Savić-Pavićević D, Brajušković G.
    Genes (Basel); 2022 Dec 09; 13(12):. PubMed ID: 36553586
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.